PKCβII augments NF-κB-dependent transcription at the CCL11 promoter via p300/CBP-associated factor recruitment and histone H4 acetylation

Journal of Immunology

Volumn 181, Issue 5, 2008, Pages 3503-3514

  Clarke, Deborah L ^a   Sutcliffe, Amy ^a   Deacon, Karl ^a   Bradbury, Dawn ^a   Corbett, Lisa ^a   Knox, Alan J ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; HISTONE ACETYLTRANSFERASE PCAF; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C BETA; TUMOR NECROSIS FACTOR ALPHA; E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, HUMAN; HISTONE; PROTEIN KINASE C; TRANSCRIPTION FACTOR RELA;

ACETYLATION; ADULT; ANIMAL CELL; ARTICLE; BREATHING MUSCLE; CHROMATIN IMMUNOPRECIPITATION; EMBRYO; ENZYME ACTIVATION; FEMALE; FIBROBLAST; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; ANIMAL; CELL CULTURE; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROMOTER REGION; PROTEIN TRANSPORT; RESPIRATORY SYSTEM;

ACETYLATION; ADULT; ANIMALS; CELLS, CULTURED; CHEMOKINE CCL11; E1A-ASSOCIATED P300 PROTEIN; FEMALE; HISTONES; HUMANS; MALE; MICE; MIDDLE AGED; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTEIN TRANSPORT; RESPIRATORY SYSTEM; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51549118740     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.5.3503     Document Type: Article

References (58)

1. Li, Q., and I. M. Verma. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2: 725-734.
2. Roth, M., and J. L. Black. 2006. Transcription factors in asthma: are transcription factors a new target for asthma therapy? Curr. Drug Targets 7: 589-595. (Pubitemid 43744825)
3. Belvisi, M. G., D. J. Hele, and M. A. Birrell. 2004. New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease. Exp. Opin. Ther. Targets 8: 265-285. (Pubitemid 39117693)
4. Sheppard, K. A., D. W. Rose, Z. K. Haque, R. Kurokawa, E. McInerney, S. Westin, D. Thanos, M. G. Rosenfeld, C. K. Glass, and T. Collins. 1999. Transcriptional activation by NF-κB requires multiple coactivators. Mol. Cell. Biol. 19: 6367-6378. (Pubitemid 29399341)
5. Ito, K., C. E. Charron, and I. M. Adcock. 2007. Impact of protein acetylation in inflammatory lung diseases. Pharmacol. Ther. 116: 249-265. (Pubitemid 47451510)
6. Barnes, P. J., I. M. Adcock, and K. Ito. 2005. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur. Respir. J. 25: 552-563. (Pubitemid 40331188)
7. Adcock, I. M., and K. Y. Lee. 2006. Abnormal histone acetylase and deacetylase expression and function in lung inflammation. Inflamm. Res. 55: 311-321.
8. Adcock, I. M., L. Tsaprouni, P. Bhavsar, and K. Ito. 2007. Epigenetic regulation of airway inflammation. Curr. Opin. Immunol. 19: 694-700.
9. 2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. J. Immunol. 175: 478-486.
10. Nie, M., L. Corbett, A. J. Knox, and L. Pang. 2005. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor γ agonists: interactions with glucocorticoids and β2-agonists. J. Biol. Chem. 280: 2550-2561. (Pubitemid 40189357)
11. Zhu, Y. M., D. A. Bradbury, L. Pang, and A. J. Knox. 2003. Transcriptional regulation of interleukin (IL)-8 by bradykinin in human airway smooth muscle cells involves prostanoid-dependent activation of AP-1 and nuclear factor (NF)- IL-6 and prostanoid-independent activation of NF-κB. J. Biol. Chem. 278: 29366-29375.
12. Nie, M., L. Pang, H. Inoue, and A. J. Knox. 2003. Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1β in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone H4 acetylation. Mol. Cell. Biol. 23: 9233-9244. (Pubitemid 37499810)
13. Miao, F., I. G. Gonzalo, L. Lanting, and R. Natarajan. 2004. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J. Biol. Chem. 279: 18091-18097. (Pubitemid 38560579)
14. Deng, W. G., Y. Zhu, and K. K. Wu. 2004. Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators. Blood 103: 2135-2142.
15. Webb, B. L., S. J. Hirst, and M. A. Giembycz. 2000. Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis. Br. J. Pharmacol. 130: 1433-1452.
16. Mallia, C. M., M. Smith, S. Clejan, and B. S. Beckman. 1997. Erythropoietin stimulates nuclear localization of diacylglycerol and protein kinase CβII in B6SUt.EP cells. J. Lipid Mediat. Cell Signal 17: 135-150.
17. Godson, C., E. Masliah, M. A. Balboa, M. H. Ellisman, and P. A. Insel. 1996. Isoform-specific redistribution of protein kinase C in living cells. Biochim. Biophys. Acta 1313: 63-71. (Pubitemid 26276239)
18. Catley, M. C., L. M. Cambridge, Y. Nasuhara, K. Ito, J. E. Chivers, A. Beaton, N. S. Holden, M. W. Bergmann, P. J. Barnes, and R. Newton. 2004. Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-κB DNA binding. J. Biol. Chem. 279: 18457-18466.
19. Bergmann, M., L. Hart, M. Lindsay, P. J. Barnes, and R. Newton. 1998. IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin- 1β and tumor necrosis factor-α-induced κB-dependent transcription: requirement for an additional activation pathway. J. Biol. Chem. 273: 6607-6610. (Pubitemid 28160316)
20. Leitges, M., C. Schmedt, R. Guinamard, J. Davoust, S. Schaal, S. Stabel, and A. Tarakhovsky. 1996. Immunodeficiency in protein kinase Cβ-deficient mice. Science 273: 788-791. (Pubitemid 26271522)
21. Tom-Moy, M., J. M. Madison, C. A. Jones, L. P. de, and J. K. Brown. 1987. Morphologic characterization of cultured smooth muscle cells isolated from the tracheas of adult dogs. Anat. Rec. 218: 313-328. (Pubitemid 17105168)
22. 2- agonists and corticosteroids. FASEB J. 15: 261-269.
23. Pang, L., M. Nie, L. Corbett, R. Donnelly, S. Gray, and A. J. Knox. 2002. Protein kinase C-ε mediates bradykinin-induced cyclooxygenase-2 expression in human airway smooth muscle cells. FASEB J. 16: 1435-1437.
24. Pang, L., M. Nie, L. Corbett, and A. J. Knox. 2003. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. J. Immunol. 170: 1043-1051. (Pubitemid 36070560)
25. Clarke, D. L., M. G. Belvisi, M. C. Catley, M. H. Yacoub, R. Newton, and M. A. Giembycz. 2004. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF. Br. J. Pharmacol. 141: 1141-1150.
26. Zhao, L., and R. D. Brinton. 2003. Vasopressin-induced cytoplasmic and nuclear calcium signaling in embryonic cortical astrocytes: dynamics of calcium and calcium-dependent kinase translocation. J. Neurosci. 23: 4228-4239. (Pubitemid 36958443)
27. Pallisgaard, N., N. Clausen, H. Schroder, and P. Hokland. 1999. Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative realtime RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer 26: 355-365. (Pubitemid 29529581)
28. 2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites. J. Biol. Chem. 280: 29993-30000.
29. Chung, K. F., H. J. Patel, E. J. Fadlon, J. Rousell, E. B. Haddad, P. J. Jose, J. Mitchell, and M. Belvisi. 1999. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1β and TNFα: effects of IL-10 and corticosteroids. Br. J. Pharmacol. 127: 1145-1150.
30. 2-adrenoceptor agonists inhibit release of eosinophil- activating cytokines from human airway smooth muscle cells. Br. J. Pharmacol. 132: 729-741.
31. Hirst, S. J., M. P. Hallsworth, Q. Peng, and T. H. Lee. 2002. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1β and is mediated by the interleukin- 4 receptor α-chain. Am. J. Respir. Crit. Care Med. 165: 1161-1171.
32. Jirousek, M. R., J. R. Gillig, C. M. Gonzalez, W. F. Heath, J. H. McDonald III, D. A. Neel, C. J. Rito, U. Singh, L. E. Stramm, A. Melikian-Badalian, et al. 1996. (S)-13-[(dimethylamino)methyl]-10,11,14,15- tetrahydro-4,9:16, 21-dimetheno- 1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13] oxadiazacyclohexadecene-1,3(2H)- dione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase Cβ. J. Med. Chem. 39: 2664-2671.
33. Gerritsen, M. E., A. J. Williams, A. S. Neish, S. Moore, Y. Shi, and T. Collins. 1997. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA 94: 2927-2932.
34. Zhong, H., M. J. May, E. Jimi, and S. Ghosh. 2002. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9: 625-636. (Pubitemid 34273792)
35. Martinez-Balbas, M. A., A. J. Bannister, K. Martin, P. Haus-Seuffert, M. Meisterernst, and T. Kouzarides. 1998. The acetyltransferase activity of CBP stimulates transcription. EMBO J. 17: 2886-2893.
36. Ventura, C., and M. Maioli. 2001. Protein kinase C control of gene expression. Crit. Rev. Eukaryotic Gene Expression 11: 243-267. (Pubitemid 32994868)
37. Rothenberg, M. E., R. Ownbey, P. D. Mehlhop, P. M. Loiselle, R. M. van de, J. V. Bonventre, H. C. Oettgen, P. Leder, and A. D. Luster. 1996. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol. Med. 2: 334-348.
38. Vermeulen, L., W. G. De, S. Notebaert, B. W. Vanden, and G. Haegeman. 2002. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit. Biochem. Pharmacol. 64: 963-970. (Pubitemid 35232270)
39. Schmitz, M. L., I. Mattioli, H. Buss, and M. Kracht. 2004. NF-κB: a multifaceted transcription factor regulated at several levels. Chembiochemistry 5: 1348-1358.
40. Beato, M. 1996. Chromatin structure and the regulation of gene expression: remodeling at the MMTV promoter. J. Mol. Med. 74: 711-724. (Pubitemid 26405601)
41. Wu, J., and M. Grunstein. 2000. 25 years after the nucleosome model: chromatin modifications. Trends Biochem. Sci. 25: 619-623.
42. Schiltz, R. L., and Y. Nakatani. 2000. The PCAF acetylase complex as a potential tumor suppressor. Biochim. Biophys. Acta 1470: M37-M53.
43. Roth, S. Y., J. M. Denu, and C. D. Allis. 2001. Histone acetyltransferases. Annu. Rev. Biochem. 70: 81-120.
44. Di, Stefano, V. S. Soddu, A. Sacchi, and G. D'Orazi. 2005. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. Oncogene 24: 5431-5442. (Pubitemid 43080087)
45. Linares, L. K., R. Kiernan, R. Triboulet, C. Chable-Bessia, D. Latreille, O. Cuvier, M. Lacroix, C. L. Le, O. Coux, and M. Benkirane. 2007. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat. Cell Biol. 9: 331-338.
46. Lallena, M. J., M. T. az-Meco, G. Bren, C. V. Paya, and J. Moscat. 1999. Activation of IκB kinase β by protein kinase C isoforms. Mol. Cell. Biol. 19: 2180-2188.
47. ras and protein kinase Cζ in primary endothelial cells. J. Biol. Chem. 274: 13594-13603.
48. Martin, A. G., B. San-Antonio, and M. Fresno. 2001. Regulation of nuclear factor κB transactivation: implication of phosphatidylinositol 3-kinase and protein kinase Cζ in c-Rel activation by tumor necrosis factor α. J. Biol. Chem. 276: 15840-15849. (Pubitemid 37391614)
49. Pavan Kumar, P., P. K. Purbey, C. K. Sinha, D. Notani, A. Limaye, R. S. Jayani, and S. Galande. 2006. Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. Mol. Cell 21: 231-243.
50. Smith, C. L., and G. L. Hager. 1997. Transcriptional regulation of mammalian genes in vivo. J. Biol. Chem. 272: 27493-27496.
51. Chen, L. F., and W. C. Greene. 2004. Shaping the nuclear action of NF-κB. Nat. Rev. Mol. Cell Biol. 5: 392-401.
52. Chen, L. F., and W. C. Greene. 2003. Regulation of distinct biological activities of the NF-κB transcription factor complex by acetylation. J. Mol. Med. 81: 549-557.
53. Chen, L. F., W. Fischle, E. Verdin, and W. C. Greene. 2001. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293: 1653-1657.
54. Chen, L. F., Y. Mu, and W. C. Greene. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J. 21: 6539-6548.
55. Adam, E., V. Quivy, F. Bex, A. Chariot, Y. Collette, C. Vanhulle, S. Schoonbroodt, V. Goffin, T. L.-A. Nguyên, G. Gloire, et al. 2003. Potentiation of tumor necrosis factor-induced NF-κB activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of IκBκ. Mol. Cell. Biol. 23: 6200-6209. (Pubitemid 37013097)
56. White, T. A., A. Xue, E. N. Chini, M. Thompson, G. C. Sieck, and M. E. Wylam. 2006. Role of transient receptor potential C3 in TNF-α-enhanced calcium influx in human airway myocytes. Am. J. Respir. Cell Mol. Biol. 35: 243-251.
57. McGill, J. B., G. L. King, P. H. Berg, K. L. Price, K. A. Kles, E. J. Bastyr, and D. L. Hyslop. 2006. Clinical safety of the selective PKC-β inhibitor, ruboxistaurin. Exp. Opin. Drug Saf. 5: 835-845.
58. Aiello, L. P., A. Clermont, V. Arora, M. D. Davis, M. J. Sheetz, and S. E. Bursell. 2006. Inhibition of PKCβ by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients. Invest. Ophthalmol. Visual Sci. 47: 86-92.